Zhongfan Ruan
Hengyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Effect of Baseline ASPECTS on Tenecteplase Efficacy Before Thrombectomy in Acute Large-Vessel Occlusion Stroke: A Post Hoc Analysis of the BRIDGE-TNK Randomized Trial.
Journal: Neurology
Published: August 20, 2026
Endovascular Treatment of Medium-Vessel-Occlusion Strokes.
Journal: The New England journal of medicine
Published: May 13, 2026
Astragaloside IV alleviates neuroinflammation in cerebral ischemia-reperfusion injury by inhibiting HTR2B-mediated microglial M1 polarization.
Journal: Neurological research
Published: July 11, 2025
Intravenous Tenecteplase before Thrombectomy in Stroke.
Journal: The New England journal of medicine
Published: May 21, 2025
Intra-Arterial Tenecteplase Following Endovascular Reperfusion for Large Vessel Occlusion Acute Ischemic Stroke: The POST-TNK Randomized Clinical Trial.
Journal: JAMA
Published: January 13, 2025
A Nationwide Prospective Registry of Endovascular Thrombectomy for Extra-Large Ischemic Stroke with Large Vessel Occlusion (XL STROKE): Rationale and Design.
Journal: Cerebrovascular diseases (Basel, Switzerland)
Published: December 14, 2024
Resveratrol Alleviates Ischemia-Reperfusion-Induced Neuronal Damage by Inhibiting NR3C2-Mediated TRIM28 Expression.
Journal: Journal of integrative neuroscience
Published: November 26, 2024
Effect of Intravenous Tirofiban Versus Placebo on First-Pass Successful Reperfusion in Endovascular Stroke Thrombectomy: Insights From the RESCUE BT Randomized Clinical Trial.
Journal: Journal of the American Heart Association
Published: November 04, 2024
Methylprednisolone as Adjunct to Endovascular Thrombectomy for Large-Vessel Occlusion Stroke: The MARVEL Randomized Clinical Trial.
Journal: JAMA
Published: February 08, 2024
Effect of direct endovascular treatment versus standard bridging therapy in large artery anterior circulation stroke (DEVT): 18-month follow-up of a randomized controlled trial.
Journal: BMC neurology
Published: November 23, 2022
HECTD3 promotes NLRP3 inflammasome and pyroptosis to exacerbate diabetes-related cognitive impairment by stabilising MALT1 to regulate JNK pathway.
Journal: Archives of physiology and biochemistry
Published: August 01, 2022
Last Updated: 09/26/2026